Amundi Pioneer Asset Management Inc. purchased a new stake in Monsanto (NYSE:MON) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 257,767 shares of the basic materials company’s stock, valued at approximately $30,103,000.
Several other large investors also recently bought and sold shares of MON. Gradient Investments LLC acquired a new stake in shares of Monsanto in the fourth quarter valued at approximately $108,000. Americafirst Capital Management LLC acquired a new stake in shares of Monsanto in the third quarter valued at approximately $148,000. McKinley Carter Wealth Services Inc. acquired a new stake in Monsanto during the fourth quarter worth $218,000. Bedel Financial Consulting Inc. acquired a new stake in Monsanto during the fourth quarter worth $244,000. Finally, Fuller & Thaler Asset Management Inc. acquired a new stake in Monsanto during the third quarter worth $264,000. 75.46% of the stock is owned by hedge funds and other institutional investors.
In other news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the transaction, the executive vice president now directly owns 56,743 shares in the company, valued at $6,772,277.05. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.79% of the company’s stock.
Monsanto (MON) opened at $123.51 on Friday. Monsanto has a 52-week low of $111.92 and a 52-week high of $124.20. The company has a market capitalization of $54,660.00, a price-to-earnings ratio of 22.83, a PEG ratio of 1.76 and a beta of 0.95. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28.
Monsanto (NYSE:MON) last released its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion for the quarter, compared to analysts’ expectations of $2.77 billion. During the same quarter in the prior year, the business earned $0.21 earnings per share. The company’s quarterly revenue was up .3% on a year-over-year basis. equities research analysts predict that Monsanto will post 5.76 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.75%. Monsanto’s dividend payout ratio is currently 39.93%.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.